Ruxience

Active Ingredient(s): Rituximab-pvvr
FDA Approved: * July 23, 2019
Pharm Company: * PFIZER INC
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Ruxience Overview

Rituximab, sold under the brand name Rituxan among others, is a medication used to treat certain autoimmune diseases and types of cancer.[3] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and Epstein–Barr virus-positive mucocutaneous ulcers.[3][4][5][6] It is ...

Read more Ruxience Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Rituximab

Recent Ruxience Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Rituximab-pvvr
  • Injection: 100mg, 100mg/10ml(10mg/ml), 10mg/ml, 500mg, 500mg/50ml(10mg/ml)
  • Solution: 100mg/10ml (10mg/ml), 500mg/50ml (10mg/ml)
  • Vial: 10mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Ruxience: (2 results)

Sorted by National Drug Code
  • 0069-0238 Ruxience 100 mg/10ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-0249 Ruxience 500 mg/50ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc

Other drugs which contain Rituximab-pvvr or a similar ingredient: (5 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 29 March 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA